Mark Austin
Finanzdirektor/CFO bei PERSPECTIVE THERAPEUTICS, INC.
Vermögen: 134 448 $ am 30.04.2024
Aktive Positionen von Mark Austin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.07.2017 | - |
| Finanzdirektor/CFO | 01.07.2017 | - | |
| Unternehmenssekretär | 15.09.2020 | - |
Karriereverlauf von Mark Austin
Ehemalige bekannte Positionen von Mark Austin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
KPMG Advisory SP ZOO Spolka Komandytowa
 KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The company is based in Warsaw, Poland. | Corporate Officer/Principal | 01.01.2009 | 01.07.2017 |
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Comptroller/Controller/Auditor | 24.07.2017 | - |
| Finanzdirektor/CFO | 24.07.2017 | - | |
| Unternehmenssekretär | 03.12.2018 | - |
Ausbildung von Mark Austin
| Santa Clara University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Polen | 2 |
| 2 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 2 |
| Corporate Secretary | 2 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
KPMG Advisory SP ZOO Spolka Komandytowa
KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The company is based in Warsaw, Poland. | Finance |
| Perspective Therapeutics, Inc. |
- Börse
- Insiders
- Mark Austin
- Erfahrung
